9/5/2016. Faculty. Cardiometabolic Risk and Impact on Bone Health. Learning Objectives. Disclosures. Osteoporosis
|
|
- Ashlynn Stevenson
- 5 years ago
- Views:
Transcription
1 Faculty Cardiometabolic Risk and Impact on Bone Health Cheryl L. Lambing, MD, FAAFP Clinical Professor Department of Family Medicine University of Calinia, Los Angeles Medical Director, Ventura County Health Care Agency Professional and Community Education and Outreach, Ventura, Calinia Disclosures Learning Objectives Dr. Lambing has disclosed no relevant financial relationships with any commercial interests. Discuss the pathophysiology and factors that contribute to higher fracture risk in cardiometabolic conditions Review the benefits and limitations of fracture risk prediction tools individuals with cardiometabolic risk Implement a patient-centered approach to managing patients with cardiometabolic conditions to reduce risk of fractures Osteoporosis Systemic skeletal disorder of compromised bone strength increased risk of fracture 43 million Americans: Low bone mass 10 million Americans: Osteoporosis Underdiagnosed and undertreated 1 in 2 women and 1 in 4 men aged >50 years will have an -related fracture in their lifetime By the year 2020, 1 in 2 Americans aged >50 years will be at risk of fractures from or low bone mass 61 million Americans with low bone mass Prediction, Diagnostic Tools, Treatment Prediction and diagnostic tools Bone densitometry with : Noninvasive test Fracture risk assessment tools to help with management decisions in patients with (eg,, Garvan Fracture Risk Calculator, QFracture ) Effective and safe s Strong evidence exercise, calcium, vitamin D sufficiency fractures and falls US Department of Health and Human Services. Bone Health and Osteoporosis: A Report of the Surgeon General. Rockville, MD: US Department of Health and Human Services, Office of the Surgeon General; Available at: Accessed July 31, International Osteoporosis Foundation Facts & Statics = dual-energy X-ray absorptiometry; = bone mineral density. National Osteoporosis Foundation. Clinician s Guide to Prevention and Treatment of Osteoporosis. Washington, DC: National Osteoporosis Foundation; Accessed July 31, Marques A, et al. Ann Rheum Dis. 2015;74(11):
2 Strong Relationship Between Bone Density and Bone Strength Relative Risk of Hip Fracture T-score Bone density accounts 60% to 80% of bone strength in untreated patients Best early predictor of fracture risk Permits diagnosis bee fractures Kushida K. Clin Calcium. 2004;14: Fogelman J, et al. J Nucl Med. 2000;41: Example: Statistically robust fracture risk prediction tool developed by the WHO worldwide use Combines + clinical risk factors to predict fracture risk better than either alone Predicts the 10-year probability of major osteoporotic fracture Hip, spine, wrist, or humerus Use when the decision to treat is uncertain >20% major -related fracture >3% hip fracture WHO = World Health Organization. Accessed September 5, When Clinical Judgment Is Needed may underestimate fracture risk Some risk factors (eg, glucocorticoids, smoking, alcohol, fractures) are dose dependent, but cannot consider dose Some risk factors that increase the risk of fractures independently of their effect on are not included in Falls Frailty Some s and medications (eg, immobilization, diabetes, hyperthyroidism, hyperparathyroidism, human immunodeficiency virus, anticonvulsants, selective serotonin receptor inhibitors, proton pump inhibitors, thiazolidinediones) Does Not Fully Predict the Increase in Fracture Risk In patients with diabetes (cardiometabolic risk): Observations and assumptions Osteoporosis, an underappreciated complication of diabetes Why? Fracture Plateau Except High-Rate Fracture Persists in Mellitus Risk Factors and Pathophysiology Frequently overweight/load bearing = Assumed protective In general, preserved, normal = Assumed protective Data demonstrate diabetes is a significant risk factor osteoporotic fractures (two-fold increase in fractures) Increase risk additional two-fold Oei L, et al. Curr Osteoporosis. 2015;13(2): Vestergaard P, et al. Osteoporos Int. 2007;18(4): Less Likely to be on National Osteoporosis Foundation. Clinician s Guide to Prevention and Treatment of Osteoporosis. Washington, DC: National Osteoporosis Foundation; Accessed July 31, Gnudi S, et al. J Bone Miner Res. 2001;16: Nguyen TV, et al. J Bone Miner Res. 2005;20: Sornay-Rendu E, et al. J Bone Miner Res. 2005;20: Agent Mellitus, Osteoporosis, and Obesity The relationship between diabetes and is under intense investigation worldwide due to prevalence of both conditions and evidence of increased fragility fractures compared with the general population (ie, non-diabetics) given any -specific level Recent developments in obesity research show that increased adiposity is characterized by greater systemic inflammation, a well-known risk factor CV, diabetes, and Fracture Prediction Tools Underestimate Fracture Risk in with Mellitus CV = cardiovascular. Oei L, et al. Curr Osteoporosis. 2015;13(2): Vestergaard P, et al. Osteoporos Int. 2007;18(4):
3 Mellitus and Osteoporosis Increased prevalence with aging Type 1 diabetes and T2DM increased risk of fractures Current diagnostic () and assessment () tools estimating are discordant Growing evidence that diabetes impacts skeletal metabolism Increased fracture risk despite higher in T2DM (eg, 69% increased risk non-vertebral fracture and fall risk) T2DM = type 2 diabetes. Oei L, et al. Curr Osteoporosis. 2015;13(2): Khazai NB, et al. Curr Opin Endocrin Care. 2009;16(6): Vestergaard P, et al. Osteoporos Int. 2007;18(4): Giangregorio LM, et al. J Bone Miner Res. 2012;27(2): Cardiometabolic Risk and Fractures with T2DM show significant and independent increased risk of fractures CV, including atherosclerosis, is more common in patients with T2DM Obesity CV Osteoporosis Atherosclerosis Risk in Communities (ARIC) Study. Oei L, et al. Curr Osteoporosis. 2015;13(2): Khazai NB, et al. Curr Opin Endocrin Care. 2009;16(6): Schneider AL, et al. Care. 2013;36(5): Pathophysiology Mellitus Advanced glycation end-products accumulate in tissue: bone, kidney, coronary arteries (impact of hyperglycemia on bone quality) Adipokines cell signaling proteins stimulate chronic inflammatory state related to development of insulin resistance T2DM Release of proinflammatory cytokines More likely to be vitamin D deficient than the general population More likely to exhibit renal insufficiency; primary/secondary hyperparathyroidism Associated with higher risk of falls (hypoglycemia, neuropathy, neuromuscular impairment, retinopathy/vision, renal impairment, stroke, medications) Pollock NK, et al. Molecul Cell Endocrinol. 2015;410: Wang C. J Res. 2013;2013: Mozos I, et al. BioMed Res Int (2015) Article ID , 12 pages. Schwartz AV, et al. JAMA. 2011;305(21): Wang C, et al. J Pediatr. 2014;90(1):4-6. Mozos I, et al. BioMed Res Int (2015) Article ID , 12 pages. Fracture Prediction Tools Underestimate Fracture Risk in with Mellitus Tools use 4-31 factors Decision making based on fracture risk, not simply T-score (10-year prediction) Most validated; most studied, best with Available online, no cost Good choice patients without fall history Garvan Fracture Risk Calculator (functional residual capacity; 5-year/10-year prediction) Requires Available on-line, no cost Better choice patients with fall history QFracture-2013 (10-year prediction) For electronic health record, most accurate Larger number and variety of risk factors Adherence/application may be limited in clinical setting due to time and length of tool Giangregorio LM, et al. J Bone Miner Res. 2012;27(2): Patient Case: Maria 65-year-old woman 5 2 ; 180 lb, BMI years post-menopause T2DM 25 years HgbA1c: 8.0% Vitamin D sufficiency 25 OH vitamin D level: 30 HgbA1c = hemoglobin A1c. 3
4 Personal History: Maria Both her mother and father as well as two siblings and two children diagnosed with T2DM Family history and personal history negative fracture Does not exercise Non-smoker Does not consume alcohol, consumes 1 tablet calcium plus vitamin D daily Takes oral medication diabetes Calcium Intake Recommendations from the Institute of Medicine Estimated Requirement Recommended Dietary Upper Level Intake Life Stage Group (mg/d) Allowance (mg/d) (mg/d) Infants 0 to 6 months * * 1000 Infants 6 to 12 months * * years old years old years old years old years old years old year-old male year-old female >70 years old years old, years old, *For infants, adequate intake is 400 IU/d 0 to 6 months of age and 400 IU/d 6 to 12 months of age. Institute of Medicine. Dietary Reference Intakes Calcium and Vitamin D: Report Brief. Washington, DC: IOM; Available at Intakes--Calcium-and-Vitamin-D.aspx. Accessed September 12, Vitamin D Intake Recommendations from the Institute of Medicine Estimated Avg Recommended Upper Level Intake Requirement Dietary Allowance (IU/d) Life Stage Group (IU/d) (IU/d) Infants 0 to 6 months * * 1000 Infants 6 to 12 months * * years old years old years old years old years old years old year-old male year-old female >70 years old years old, years old, *For infants, adequate intake is 400 IU/d 0 to 6 months of age and 400 IU/d 6 to 12 months of age. Institute of Medicine. Dietary Reference Intakes Calcium and Vitamin D: Report Brief. Washington, DC: IOM; Available at Intakes--Calcium-and-Vitamin-D.aspx. Accessed September 12, Maria ordered routinely at aged 65 years based on standard evidence Recommendation preventive health US Preventive Services Task Force. USPSTF: Ann Intern Med Jan Accessed September 5, Maria with : Aged 65 Years Clinical Practice Annals of the Rheumatic Diseases: The EULAR Journal. June vol 75, 5(2). Schwartz AV, et al. JAMA. 2011;305(21): Presented at American Society Bone and Mineral Research (ASBMR) 2015 Annual Meeting Oct 9-12, 2015, Seattle USA. Leslie W et al., Obesity and Fracture Risk Assessment: Paradox and Progress. 4
5 Maria with Personal Fracture Clinical Practice Personal fracture 20% 4.2% high risk EULAR J. June 2016;75, 5(2). Schwartz AV, et al. JAMA. 2011;305(21): Leslie W, et al., Obesity and Fracture Risk Assessment: Paradox and Progress. Presented at American Society Bone and Mineral Research (ASBMR) 2015 Annual Meeting Oct 9-12, 2015, Seattle, WA. Clinical Practice (cont) Maria with DM Surrogate Risk Personal fracture 20% 4.2% high risk Re T2DM (five-fold increased risk of fracture) Surrogate risk EULAR J. June 2016;75, 5(2). Schwartz AV, et al. JAMA. 2011;305(21): Leslie W, et al., Obesity and Fracture Risk Assessment: Paradox and Progress. Presented at American Society Bone and Mineral Research (ASBMR) 2015 Annual Meeting Oct 9-12, 2015, Seattle, WA. Clinical Practice Maria with Surrogate Risk + Fracture Personal fracture 20% 4.2% high risk Re T2DM (five-fold increased risk of fracture) Major fracture: 16% Hip fracture: 3.6% EULAR J. June 2016;75, 5(2). Leslie W, et al., Obesity and Fracture Risk Assessment: Paradox and Progress. Presented at American Society Bone and Mineral Research (ASBMR) 2015 Annual Meeting Oct 9-12, 2015, Seattle, WA. 5
6 Underestimates Fracture Risk in with Mellitus does not explain fracture risk Women with T2DM have increased cortical porosity; increased trabecular volumetric density changes not captured with Factors stimulate adipogenesis; inhibit osteoblast differentiation Falls are not captured in (peripheral neuropathy, vision impairment) Medication (thiazolidinediones) Hyperglycemia (advanced glycation end-products); hyperinsulinemia -specific factors increase fracture risk (retinopathy, cataracts, renal impairment, insulin, hypoglycemia, duration of diabetes ) Cellular signaling pathways (abnormal cytokines and adipokines) Giangregorio LM, et al. J Bone Miner Res. 2012;27(2): Mellitus is an Independent Risk Factor Fracture 10-Year Probability of Symptomatic Fracture (%) Age 65 Surrogate % Fx Risk 3.6% Hip Fx Risk Age 65 T-score % Fx Risk 2.5% Hip Fx Risk Black DM, et al. J Bone Mineral Res. 2012;27(2): EULAR J. June 2016;75, 5(2). Leslie W, et al., Obesity and Fracture Risk Assessment: Paradox and Progress. Presented at American Society Bone and Mineral Research (ASBMR) 2015 Annual Meeting Oct 9-12, 2015, Seattle, WA. Pathophysiologic Defects in Hyperglycemia and Obesity increased appetite incretin effect gut carbohydrate delivery and absorption pancreatic insulin secretion pancreatic glucagon secretion HYPERGLYCEMIA stress hormones leptin Additional Risks - hepatic glucose production osteocalcin - Proinflammatory Cytokines peripheral glucose uptake Goldman's Cecil Medicine. 24th ed. New York, NY: Elsevier Saunders; Osteoporosis: What Are the Risk Factors? Non-Modifiable Risk Factors Age Female gender Family history of Previous fracture Ethnicity Menopause/hysterectomy Long-term glucocorticoid therapy Rheumatoid arthritis Primary/secondary/hypogonadism in men International Osteoporosis Foundation. Who s at Risk? http// Modifiable Risk Factors Alcohol Smoking Low BMI Poor nutrition Vitamin D deficiency Low dietary calcium intake Eating disorders Insufficient exercise Frequent falls Variance gene and response to DNA binding Role of Vitamin D Activated Vitamin D Binds Vitamin D Receptor (VDR) Cellular nucleus Activators/Suppressors binds DNA Impact gene expression >200 genes directly/indirectly Wang C, et al. J Pediatr. 2014;90 (1):4-6. Vacek JL, et al. Am J Cardiol. 2010;106:798. Wang C. J Res. 2013;2013: Mozos I, et al. BioMed Res Int (2015) Article ID , 12 pages. Gene polymorphisms 6
7 Receptors Vitamin D Vitamin D Gastrointestinal (enterocytes) Bone (osteoblasts) Parathyroid gland Kidney (renal tubule cells) Liver (hepatocytes) Immune system Skeletal muscle Cardiac muscle (cardiomyocytes) Vascular endothelial cells (vascular smooth muscle cells) Central nervous system (neurons) Pancreas (B cells) Epithelial cells Wang C, et al. J Pediatr. 2014;90 (1):4-6. Vacek JL, et al. Am J Cardiol. 2010;106:798. Wang C. J Res. 2013;2013: Mozos I, et al. BioMed Res Int (2015) Article ID , 12 pages. Marenzi G, et al. Medicine. 2015;94 (1):1-8. CV Lower systolic blood pressure Lower vascular resistance Lower arterial intima thickness Increased insulin secretion/sensitivity Lower very lowdensity lipoprotein and triglycerides Effect on myocardial contractility Decreased inflammatory cytokines References Vacek JL, et al. Am J Cardiol. 2010;106: Activated Bone-related health VitaD binds in cells to VDR Calcium - phosphate (Vitamin D Receptor) Homeostasis regulation Deficiency associated with variety of s: Hypertension, diabetes, autoimmune, colon cancer To Improve Clinical Outcomes, Clinical Considerations Assess dietary intakes calcium and vitamin D Ensure vitamin D sufficiency Avoid calcium supplementation without vitamin D In patients with a CV event, screen underlying (altered bone quality risk) In patients with fractures assess CV risk Assess patients with diabetes adequate bone health and fall risk; maintain HgbA1c at goal Address overlapping CV risks (eg, age, smoking, inflammation, activity) Avoid under of patients with diabetes who are at increased risk Khazai NB, et al. Curr Opin Endocrinol Obes Dec;16(6): Vestergaard P, et al. BMJ. 2016:1-9. American Association. Care. 2016;39(9):1653. Best Evidence Vitamin D sufficiency appears to be of benefit improved bone health, fall risk, and a variety of cardiometabolic effects No guidelines; mounting evidence; clinical recommendations based on current evidence Vitamin D deficiency may be considered a CV risk marker Wang C, et al. J Pediatr. 2014;90 (1):4-6. Vacek JL, et al. Am J Cardiol. 2010;106:798. Wang C. J Res. 2013;2013: Mozos I, et al. BioMed Res Int (2015) Article ID , 12 pages. Marenzi G, et al. Medicine. 2015;94 (1):1-8. Take-Home Points is considered an independent risk factor fracture The hazard ratio is comparable to or even greater than many of the current tool factors and other prediction tools Questions? Modeling to ensure future fracture prediction tool(s) accurate across populations Maintain low index of suspicion increased fracture risk Assess dietary intakes, ensure vitamin D sufficiency, and avoid calcium without vitamin D 7
Skeletal Manifestations
Skeletal Manifestations of Metabolic Bone Disease Mishaela R. Rubin, MD February 21, 2008 The Three Ages of Women Gustav Klimt 1905 1 Lecture Outline Osteoporosis epidemiology diagnosis secondary causes
More informationLearning Objectives. Controversies in Osteoporosis Prevention and Management. Etiology. Presenter Disclosure Information. Epidemiology.
12:45 1:30pm Controversies in Osteoporosis Prevention and Management SPEAKER Carolyn Crandall, MD, MS Presenter Disclosure Information The following relationships exist related to this presentation: Carolyn
More informationThey are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:
: assessing the risk of fragility fracture bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They are updated regularly as new
More informationCase Finding and Risk Assessment for Osteoporosis
Case Finding and Risk Assessment for Osteoporosis Patient may present as a fragility fracture or risk fracture Fragility fracture age 50 Clinical risk factors aged 50 Very strong clinical risk factors
More informationBAD TO THE BONE. Peter Jones, Rheumatologist QE Health, Rotorua. GP CME Conference Rotorua, June 2008
BAD TO THE BONE Peter Jones, Rheumatologist QE Health, Rotorua GP CME Conference Rotorua, June 2008 Agenda Osteoporosis in Men Vitamin D and Calcium Long-term treatment with Bisphosphonates Pathophysiology
More informationUsing the FRAX Tool. Osteoporosis Definition
How long will your bones remain standing? Using the FRAX Tool Gary Salzman M.D. Director Banner Good Samaritan/ Hayden VAMC Internal Medicine Geriatric Fellowship Program Phoenix, Arizona Using the FRAX
More informationInterpreting DEXA Scan and. the New Fracture Risk. Assessment. Algorithm
Interpreting DEXA Scan and the New Fracture Risk Assessment Algorithm Prof. Samir Elbadawy *Osteoporosis affect 30%-40% of women in western countries and almost 15% of men after the age of 50 years. Osteoporosis
More informationFRAX, NICE and NOGG. Eugene McCloskey Professor of Adult Bone Diseases University of Sheffield
FRAX, NICE and NOGG Eugene McCloskey Professor of Adult Bone Diseases University of Sheffield Disclosures Research funding and/or honoraria and/or advisory boards for: o ActiveSignal, Amgen, Bayer, Boehringer
More informationOsteoporosis: An Overview. Carolyn J. Crandall, MD, MS
Osteoporosis: An Overview Carolyn J. Crandall, MD, MS Osteoporosis: An Overview Carolyn J. Crandall, MD, MS Professor of Medicine David Geffen School of Medicine at UCLA Objectives Review osteoporosis
More informationThe Skeletal Response to Aging: There s No Bones About It!
The Skeletal Response to Aging: There s No Bones About It! April 7, 2001 Joseph E. Zerwekh, Ph.D. Interrelationship of Intestinal, Skeletal, and Renal Systems to the Overall Maintenance of Normal Calcium
More informationChapter 39: Exercise prescription in those with osteoporosis
Chapter 39: Exercise prescription in those with osteoporosis American College of Sports Medicine. (2010). ACSM's resource manual for guidelines for exercise testing and prescription (6th ed.). New York:
More informationLearning Objectives. Controversies in Osteoporosis Prevention and Management. Definition. Presenter Disclosure Information.
4 4:45 pm Controversies in Osteoporosis Prevention and Management SPEAKER Carolyn Crandall, MD, MS Presenter Disclosure Information The following relationships exist related to this presentation: Carolyn
More informationEndocrine Regulation of Calcium and Phosphate Metabolism
Endocrine Regulation of Calcium and Phosphate Metabolism Huiping Wang ( 王会平 ), PhD Department of Physiology Rm C516, Block C, Research Building, School of Medicine Tel: 88208252 Email: wanghuiping@zju.edu.cn
More informationVitamin D: Conflict of Interest Statement Corporate. Outline 7/5/2016
Vitamin D: What s New and Not? Clifford J Rosen MD Maine Medical Center Research Institute rosenc@mmc.org Conflict of Interest Statement Corporate NO STOCKS or EQUITY Editor UpToDate, New England Journal
More informationDiabesity. Metabolic dysfunction that ranges from mild blood glucose imbalance to full fledged Type 2 DM Signs
Diabesity Metabolic dysfunction that ranges from mild blood glucose imbalance to full fledged Type 2 DM Signs Abdominal obesity Low HDL, high LDL, and high triglycerides HTN High blood glucose (F>100l,
More informationVitamin D: Is it a superhero??
Vitamin D: Is it a superhero?? Dr. Ashraf Abdel Basset Bakr Prof. of Pediatrics 1 2 History of vitamin D discovery Sources of vitamin D and its metabolism 13 Actions of vitamin D 4 Vitamin D deficiency
More informationAutonomic neuropathy
3. Neuropathy Autonomic neuropathy MACROVASCULAR: Accelerated atherosclerosis Coronary artery disease IHD / MI Cerebrovascular disease CVA Peripheral vascular disease gangrene / amputations NB: association
More informationOSTEOPOROSIS IN INDONESIA
OSTEOPOROSIS IN INDONESIA Hana Ratnawati Faculty of Medicine Maranatha Christian University Bandung - Indonesia 5th SBA Conference 2013 1 5th SBA Conference 2013 2 INTRODUCTION Indonesia is an archipelago
More informationVitamin D & Cardiovascular Disease
Vitamin D & Cardiovascular Disease Disclosures None Vitamin D Objectives: Discuss the basics of vitamin D metabolism Discuss the role of vitamin D deficiency in the development of coronary disease Review
More informationCalcium Nephrolithiasis and Bone Health. Noah S. Schenkman, MD
Calcium Nephrolithiasis and Bone Health Noah S. Schenkman, MD Associate Professor of Urology and Residency Program Director, University of Virginia Health System; Charlottesville, Virginia Objectives:
More informationDisclosure and Conflicts of Interest Steven T Harris MD Osteoporosis Diagnosis: BMD, FRAX and Assessment of Secondary Osteoporosis
Osteoporosis Diagnosis: BMD, FRAX and Assessment of Secondary Osteoporosis Steven T Harris MD FACP Clinical Professor of Medicine University of California, San Francisco Disclosure and Conflicts of Interest
More informationLOVE YOUR BONES Protect your future
www.worldosteoporosisday.org LOVE YOUR BONES Protect your future Know your risk for osteoporosis www.iofbonehealth.org Osteoporosis is a problem worldwide, and in many countries, up to one in three women
More informationOsteoporosis/Fracture Prevention
Osteoporosis/Fracture Prevention NATIONAL GUIDELINE SUMMARY This guideline was developed using an evidence-based methodology by the KP National Osteoporosis/Fracture Prevention Guideline Development Team
More informationIndex. Note: Page numbers of article titles are in boldface type.
Heart Failure Clin 2 (2006) 101 105 Index Note: Page numbers of article titles are in boldface type. A ACE inhibitors, in diabetic hypertension, 30 31 Adipokines, cardiovascular events related to, 6 Advanced
More informationAn audit of osteoporotic patients in an Australian general practice
professional Darren Parker An audit of osteoporotic patients in an Australian general practice Background Osteoporosis is a major contributor to morbidity and mortality in Australia, and is predicted to
More informationLearning Objectives. ! Students will become familiar with the 3 treatment solutions for osteoporosis. ! Students should be able to define osteoporosis
Learning Objectives! Students should be able to define osteoporosis! Students should be able to identify some risk factors of osteoporosis! Students should be able to identify some of the people in the
More informationThe Role of the Laboratory in Metabolic Bone Disease
The Role of the Laboratory in Metabolic Bone Disease Howard Morris PhD, FAACB, FFSc(RCPA) President, IFCC Professor of Medical Sciences, University of South Australia, Clinical Scientist, SA Pathology
More informationHIV Infection as a Chronic Disease. Howard Libman, MD Beth Israel Deaconess Medical Center Harvard Medical School
HIV Infection as a Chronic Disease Howard Libman, MD Beth Israel Deaconess Medical Center Harvard Medical School Role of Primary Care Approximately 50,000 patients are diagnosed with HIV infection annually
More informationDM and Osteoporosis. Why is it important?
DM and Osteoporosis Why is it important? Diabetes Osteoporosis Fractures Dr Pedro Conthe HGUGM Madrid Spain Agenda: DM and Osteoporosis Observational studies Physiopathology of bone Type I and Type 2 DM
More informationHemoglobin. What is it? Why is iron important? What food sources contain iron?
Hemoglobin What is it? Why is iron important? What food sources contain iron? Poor Diet Lack of Iron and B12 vitamins in the diet Blood Loss Pregnancy Genetics Fatigue due to cells and tissues not being
More informationBMD: A Continuum of Risk WHO Bone Density Criteria
Pathogenesis of Osteoporosis Osteoporosis Diagnosis: BMD, FRAX and Assessment of Secondary Osteoporosis AGING MENOPAUSE OTHER RISK FACTORS RESORPTION > FORMATION Bone Loss LOW PEAK BONE MASS Steven T Harris
More informationModule 5 - Speaking of Bones Osteoporosis For Health Professionals: Fracture Risk Assessment. William D. Leslie, MD MSc FRCPC
Module 5 - Speaking of Bones Osteoporosis For Health Professionals: Fracture Risk Assessment William D. Leslie, MD MSc FRCPC Case #1 Age 53: 3 years post-menopause Has always enjoyed excellent health with
More informationOsteoporosis: Risk Factors, Diagnostic Methods And Treatment Options
ISPUB.COM The Internet Journal of Academic Physician Assistants Volume 1 Number 1 Osteoporosis: Risk Factors, Diagnostic Methods And Treatment Options K Ihrke Citation K Ihrke.. The Internet Journal of
More informationWelcome and Introduction
Welcome and Introduction This presentation will: Define obesity, prediabetes, and diabetes Discuss the diagnoses and management of obesity, prediabetes, and diabetes Explain the early risk factors for
More informationOsteoporosis. Treatment of a Silently Developing Disease
Osteoporosis Treatment of a Silently Developing Disease Marc K. Drezner, MD Senior Associate Dean Emeritus Professor of Medicine Emeritus University of Wisconsin-Madison Auditorium The Forest at Duke October
More informationOral Hypoglycemics and Risk of Adverse Cardiac Events: A Summary of the Controversy
Oral Hypoglycemics and Risk of Adverse Cardiac Events: A Summary of the Controversy Jeffrey Boord, MD, MPH Advances in Cardiovascular Medicine Kingston, Jamaica December 7, 2012 VanderbiltHeart.com Outline
More informationEmerging Areas Relating Vitamin D to Health
ILSI SEA Region Vit D Conference, Australia, June 2012 (www.ilsi.org/sea Region) Emerging Areas Relating Vitamin D to Health Peter R Ebeling MD FRACP NorthWest Academic Centre and Dept Endocrinology The
More information1
www.osteoporosis.ca 1 2 Overview of the Presentation Osteoporosis: An Overview Bone Basics Diagnosis of Osteoporosis Drug Therapies Risk Reduction Living with Osteoporosis 3 What is Osteoporosis? Osteoporosis:
More informationSKELETAL FRAGILITY AND FRACTURE RISK IN PATIENTS WITH DIABETES
SKELETAL FRAGILITY AND FRACTURE RISK IN PATIENTS WITH DIABETES Nelson B. Watts, MD OSTEOPOROSIS AND BONE HEALTH SERVICES CINCINNATI, OHIO DISCLOSURES Stock options/holdings, company owner, official role:
More informationScreening Guidelines: Women
The Situation 1 in 2 postmenopausal women and 1 in 5 older men will have an osteoporosis-related fracture in their lifetimes Osteoporosis Definition NIH Consensus Conference A skeletal disorder characterized
More informationFOCUS ON CARDIOVASCULAR DISEASE
The Consequences of Vitamin D Deficiency: FOCUS ON CARDIOVASCULAR DISEASE Vitamin D deficiency is a global health problem. With all the medical advances of the century, vitamin D deficiency is still epidemic.
More informationOsteoporosis challenges
Osteoporosis challenges Osteoporosis challenges Who should have a fracture risk assessment? Who to treat? Drugs, holidays and unusual adverse effects Fracture liaison service? The size of the problem 1
More informationBone Mass Measurement BONE MASS MEASUREMENT HS-042. Policy Number: HS-042. Original Effective Date: 8/25/2008
Easy Choice Health Plan, Inc. Harmony Health Plan of Illinois, Inc. Missouri Care, Inc. Ohana Health Plan, a plan offered by WellCare Health Insurance of Arizona, Inc. WellCare Health Insurance of Illinois,
More informationWhat systems are involved in homeostatic regulation (give an example)?
1 UNIVERSITY OF PNG SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES DISCIPLINE OF BIOCHEMISTRY AND MOLECULAR BIOLOGY GLUCOSE HOMEOSTASIS (Diabetes Mellitus Part 1): An Overview
More informationBone Metabolism in Postmenopausal Women Influenced by the Metabolic Syndrome
Bone Metabolism in Postmenopausal Women Influenced by the Metabolic Syndrome Thomas et al. Nutrition Journal (2015) 14:99 DOI 10.1186/s12937-015-0092-2 RESEARCH Open Access Acute effect of a supplemented
More informationChallenging the Current Osteoporosis Guidelines. Carolyn J. Crandall, MD, MS Professor of Medicine David Geffen School of Medicine at UCLA
Challenging the Current Osteoporosis Guidelines Carolyn J. Crandall, MD, MS Professor of Medicine David Geffen School of Medicine at UCLA Whom to screen Which test How to diagnose Whom to treat Benefits
More informationTo understand bone growth and development across the lifespan. To develop a better understanding of osteoporosis.
Nutrition Aspects of Osteoporosis Care and Treatment t Cynthia Smith, FNP-BC, RN, MSN, CCD Pars Osteoporosis Clinic, Belpre, OH. Objectives To understand bone growth and development across the lifespan.
More informationNon-insulin treatment in Type 1 DM Sang Yong Kim
Non-insulin treatment in Type 1 DM Sang Yong Kim Chosun University Hospital Conflict of interest disclosure None Committee of Scientific Affairs Committee of Scientific Affairs Insulin therapy is the mainstay
More informationIEHP UM Subcommittee Approved Authorization Guidelines DEXA Scan
Policy: IEHP UM Subcommittee Approved Authorization Guidelines IEHP considers bone mineral density testing using DEXA medically necessary for members who meet any of the following criteria: Women aged
More information2017 Hot topics in cardiometabolism: an interactive update
14-15 July, 2017 - Bogotà, Colombia 2017 Hot topics in cardiometabolism: an interactive update IMPROVING THE PATIENT S LIFE THROUGH MEDICAL EDUCATION www.excemed.org Nicola Napoli Department of Medicine,
More information3/20/2011. Body Mass Index (kg/[m 2 ]) Age at Issue (*BMI > 30, or ~ 30 lbs overweight for 5 4 woman) Mokdad A.H.
U.S. Adults: 1988 Nineteen states with 10-14% 14% Prevalence of Obesity (*BMI > 30, or ~ 30 lbs overweight for 5 4 woman) Metabolic John P. Cello, MD Professor of Medicine and Surgery, University of California,
More informationFragile Bones and how to recognise them. Rod Hughes Consultant physician and rheumatologist St Peter s hospital Chertsey
Fragile Bones and how to recognise them Rod Hughes Consultant physician and rheumatologist St Peter s hospital Chertsey Osteoporosis Osteoporosis is a skeletal disorder characterised by compromised bone
More informationDiabetes Mellitus in the Pediatric Patient
Diabetes Mellitus in the Pediatric Patient William Bryant, M.D. Chief of Section Pediatric Endocrinology Children s Hospital at Scott & White Texas A&M University Temple, Texas Disclosures None Definitions
More informationNutritional Aspects of Osteoporosis Care and Treatment Cynthia Smith, FNP-BC, RN, MSN, CCD Pars Osteoporosis Clinic, Belpre, Ohio
Osteoporosis 1 Nutritional Aspects of Osteoporosis Care and Treatment Cynthia Smith, FNP-BC, RN, MSN, CCD Pars Osteoporosis Clinic, Belpre, Ohio 1) Objectives: a) To understand bone growth and development
More informationOsteoporosis in Men Wendy Rosenthal PharmD. This program has been brought to you by PharmCon
Osteoporosis in Men Wendy Rosenthal PharmD This program has been brought to you by PharmCon Osteoporosis in Men Speaker: Dr. Wendy Rosenthal, President of MedOutcomes, will be the presenter for this webcast.
More informationInternational Journal of Health Sciences and Research ISSN:
International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article Osteoporosis- Do We Need to Think Beyond Bone Mineral Density? Dr Preeti Soni 1, Dr Shipra
More informationBad to the Bones: Diabetes and Thiazolidinediones 9/9/2010. Steven Ing, MD, MSCE Assistant Professor Division of Endocrinology, Diabetes & Metabolism
Bad to the Bones: Diabetes and Thiazolidinediones 9/9/2010 Steven Ing, MD, MSCE Assistant Professor Division of Endocrinology, Diabetes & Metabolism Any reduction of bone mass in diabetics that is revealed
More informationUNIVERSITY OF PNG SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES DISCIPLINE OF BIOCHEMISTRY AND MOLECULAR BIOLOGY
1 UNIVERSITY OF PNG SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES DISCIPLINE OF BIOCHEMISTRY AND MOLECULAR BIOLOGY GLUCOSE HOMEOSTASIS An Overview WHAT IS HOMEOSTASIS? Homeostasis
More informationThe Many Faces of T2DM in Long-term Care Facilities
The Many Faces of T2DM in Long-term Care Facilities Question #1 Which of the following is a risk factor for increased hypoglycemia in older patients that may suggest the need to relax hyperglycemia treatment
More informationPage 1. New Developments in Osteoporosis. What s New in Osteoporosis
New Developments in Osteoporosis Eliseo J. Pérez-Stable MD Professor of Medicine Division of General Internal Medicine Department of Medicine July 4, 2013 Declaration of full disclosure: No conflict of
More informationOsteoporosis: fragility fracture risk. Costing report. Implementing NICE guidance
Osteoporosis: fragility fracture risk Costing report Implementing NICE guidance August 2012 NICE clinical guideline 146 1 of 15 This costing report accompanies the clinical guideline: Osteoporosis: assessing
More informationDual-energy X-ray absorptiometry (DXA), body composition assessment 62
Subject Index 3 -Adrenergic receptor, gene polymorphisms and obesity 10 Aging, body composition effects 64, 65 Air-displacement plethysmography, body composition assessment 62 Bioelectrical impedance analysis
More informationIndex. Rheum Dis Clin N Am 32 (2006) Note: Page numbers of article titles are in boldface type.
Rheum Dis Clin N Am 32 (2006) 775 780 Index Note: Page numbers of article titles are in boldface type. A AACE (American Association of Clinical Endocrinologists), bone mineral density recommendations of,
More informationFunctional Blood Chemistry & CBC Analysis
Functional Blood Chemistry & CBC Analysis Session 10 Inflammation Markers The 19 Deadly Sins of Heart Disease 1. Excess LDL 2. Excess Total cholesterol 3. Low HDL 4. Excess Triglycerides 5. Oxidized LDL
More informationOsteoporosis Screening and Treatment in Type 2 Diabetes
Osteoporosis Screening and Treatment in Type 2 Diabetes Ann Schwartz, PhD! Dept. of Epidemiology and Biostatistics! University of California San Francisco! October 2011! Presenter Disclosure Information
More informationAMERICAN COLLEGE OF RHEUMATOLOGY POSITION STATEMENT. Committee on Rheumatologic Care
AMERICAN COLLEGE OF RHEUMATOLOGY POSITION STATEMENT SUBJECT: PRESENTED BY: FOR DISTRIBUTION TO: Bone Mineral Density Measurement and the Role of Rheumatologists in the Management of Osteoporosis Committee
More informationClinician s Guide to Prevention and Treatment of Osteoporosis
Clinician s Guide to Prevention and Treatment of Osteoporosis Published: 15 August 2014 committee of the National Osteoporosis Foundation (NOF) Tipawan khiemsontia,md outline Basic pathophysiology screening
More informationPage 1
Osteoporosis Osteoporosis is a condition characterised by weakened bones that fracture easily. After menopause many women are at risk of developing osteoporosis. Peak bone mass is usually reached during
More informationWhat Is FRAX & How Can I Use It?
What Is FRAX & How Can I Use It? Jacqueline Osborne PT, DPT Board Certified Geriatric Clinical Specialist Certified Exercise Expert for the Aging Adult Brooks Rehabilitation; Jacksonville, FL Florida Physical
More informationBONE REMODELLING. Tim Arnett. University College London. Department of Anatomy and Developmental Biology
BONE REMODELLING Tim Arnett Department of Anatomy and Developmental Biology University College London The skeleton, out of sight and often out of mind, is a formidable mass of tissue occupying about 9%
More informationChapter 18. Diet and Health
Chapter 18 Diet and Health Risk Factors and Chronic Diseases Interrelationships among Chronic Diseases Chronic Disease Heart Disease and Stroke Hypertension Cancer Diabetes The Formation of Plaques in
More informationChapter 20. Endocrine System Chemical signals coordinate body functions Chemical signals coordinate body functions. !
26.1 Chemical signals coordinate body functions Chapter 20 Endocrine System! Hormones Chemical signals Secreted by endocrine glands Usually carried in the blood Cause specific changes in target cells Secretory
More informationOsteoporosis: A Tale of 3 Task Forces!
Osteoporosis: A Tale of 3 Task Forces! Robert A. Adler, MD McGuire Veterans Affairs Medical Center Virginia Commonwealth University Richmond, Virginia, USA Disclosures The opinions are those of the speaker
More informationCommon Diabetes-related Terms
Common Diabetes-related Terms A1C An A1C test measures a person's average blood glucose level over two to three months. Hemoglobin is the part of a red blood cell that carries oxygen to the cells and sometimes
More informationOfficial Positions on FRAX
196 96 DEPLIANT 3,5x8,5.indd 1 2010 Official Positions on FRAX 21.03.11 11:45 Interpretation and Use of FRAX in Clinical Practice from the International Society for Clinical Densitometry and International
More informationAdrenal gland And Pancreas
Adrenal gland And Pancreas Structure Cortex Glucocorticoids Effects Control of secretion Mineralocorticoids Effects Control of secretion Sex steroids Medulla Catecholamines Adrenal cortex 80% of an adrenal
More informationCHAPTER 50 Endocrine Systems. Copyright The McGraw-Hill Companies, Inc. Permission required for reproduction or display.
CHAPTER 50 Endocrine Systems Copyright The McGraw-Hill Companies, Inc. Permission required for reproduction or display. Endocrine system All the endocrine glands and other organs with hormonesecreting
More informationClosing the Care Gap in Osteoporosis ICE Conference 2015
Closing the Care Gap in Osteoporosis ICE Conference 2015 Pat McCarthy-Briggs RD, MHEd Thank You! What is osteoporosis? a systemic skeletal disease characterized by low bone mass and microarchitectural
More informationHelpful information about bone health & osteoporosis Patient Resource
Helpful information about bone health & osteoporosis Patient Resource Every year In the United States, 2.5 million fractures occur due to osteoporosis. Out of these, 330,000 are hip fractures, and half
More information8/6/2018. Glucocorticoid induced osteoporosis: overlooked and undertreated? Disclosure. Objectives. Overview
Disclosure Glucocorticoid induced osteoporosis: overlooked and undertreated? I have no financial disclosure relevant to this presentation Tasma Harindhanavudhi, MD Division of Diabetes and Endocrinology
More informationCASE 1 WHY IS IT IMPORTANT TO TREAT? FACTS CONCERNS
4:30-5:15pm Ask the Expert: Osteoporosis SPEAKERS Silvina Levis, MD OSTEOPOROSIS - FACTS 1:3 older women and 1:5 older men will have a fragility fracture after age 50 After 3 years of treatment, depending
More informationCorrelation between Thyroid Function and Bone Mineral Density in Elderly People
IBBJ Spring 2016, Vol 2, No 2 Original Article Correlation between Thyroid Function and Bone Mineral Density in Elderly People Ali Mirzapour 1, Fatemeh Shahnavazi 2, Ahmad Karkhah 3, Seyed Reza Hosseini
More informationMETABOLIC SYNDROME IN REPRODUCTIVE FEMALES
METABOLIC SYNDROME IN REPRODUCTIVE FEMALES John J. Orris, D.O., M.B.A Division Head, Reproductive Endocrinology & Infertility, Main Line Health System Associate Professor, Drexel University College of
More informationSupplementary on line
Supplementary on line French recommendations for CV, infection, cancer and osteoporotic fracture risks in rheumatoid arthritis.[1] Cardiovascular disease Cardiovascular risk should be assessed annually
More informationHyperparathyroidism: Operative Considerations. Financial Disclosures: None. Hyperparathyroidism. Hyperparathyroidism 11/10/2012
Hyperparathyroidism: Operative Considerations Financial Disclosures: None Steven J Wang, MD FACS Associate Professor Dept of Otolaryngology-Head and Neck Surgery University of California, San Francisco
More informationDownload slides:
Download slides: https://www.tinyurl.com/m67zcnn https://tinyurl.com/kazchbn OSTEOPOROSIS REVIEW AND UPDATE Boca Raton Regional Hospital Internal Medicine Conference 2017 Benjamin Wang, M.D., FRCPC Division
More informationDiabetes Day for Primary Care Clinicians Advances in Diabetes Care
Diabetes Day for Primary Care Clinicians Advances in Diabetes Care Elliot Sternthal, MD, FACP, FACE Chair New England AACE Diabetes Day Planning Committee Welcome and Introduction This presentation will:
More informationMetabolic Syndrome. DOPE amines COGS 163
Metabolic Syndrome DOPE amines COGS 163 Overview - M etabolic Syndrome - General definition and criteria - Importance of diagnosis - Glucose Homeostasis - Type 2 Diabetes Mellitus - Insulin Resistance
More informationOSTEOPOROSIS: PREVENTION AND MANAGEMENT
OSTEOPOROSIS: OVERVIEW OSTEOPOROSIS: PREVENTION AND MANAGEMENT Judith Walsh, MD, MPH Departments of Medicine and Epidemiology and Biostatistics UCSF Definitions Key Risk factors Screening and Monitoring
More informationRisk Factors for Postmenopausal Fractures What We Have Learned from The OSTPRE - study
Risk Factors for Postmenopausal Fractures What We Have Learned from The OSTPRE - study Heikki Kröger Kuopio Musculoskeletal Research Unit, University of Eastern Finland (UEF) Dept. of Orthopaedics, Traumatology
More informationVitamin D Replacement ROCKY MOUNTAIN MEETING NOV 2013 BANFF W.COKE UNIVERSITY OF TORONTO
Vitamin D Replacement ROCKY MOUNTAIN MEETING NOV 2013 BANFF W.COKE UNIVERSITY OF TORONTO Disclosures: (Academic Mea Culpa) No financial conflicts I have no expertise re: Vitamin D. OBJECTIVES: 1) Review
More informationARGININE VASOPRESSIN (AVP)
ARGININE VASOPRESSIN (AVP) AFFECTS BLOOD PRESSURE AND RENAL WATER REABSORPTION WHAT ELSE DOES IT DO? Michael F. Michelis, M.D., F.A.C.P., F.A.S.N. Director, Division of Nephrology Lenox Hill Hospital,
More informationChanging Diabetes: The time is now!
Midwest Cardiovascular Research Foundation Welcomes DANITA HARRISON, ARNP Ms. Harrison discloses speaking relationships with Lilly, Novo Nordisk and Pfizer. Changing Diabetes: The time is now! Danita Harrison
More informationStudy of secondary causes of male osteoporosis
Study of secondary causes of male osteoporosis Suárez, S.M., Giunta J., Meneses G., Costanzo P.R., Knoblovits P. Department of Endocrinology, Metabolism and Nuclear Medicine of Hospital Italiano of Buenos
More informationGLP 1 agonists Winning the Losing Battle. Dr Bernard SAMIA. KCS Congress: Impact through collaboration
GLP 1 agonists Winning the Losing Battle Dr Bernard SAMIA KCS Congress: Impact through collaboration CONTACT: Tel. +254 735 833 803 Email: kcardiacs@gmail.com Web: www.kenyacardiacs.org Disclosures I have
More information10 Essential Blood Tests PART 2
Presents 10 Essential Blood Tests PART 2 The Blood Chemistry Webinars With DR. DICKEN WEATHERBY Creator of the Blood Chemistry Software Heart Disease, Inflammation, & Essential Blood Tests #2 to #4: Fibrinogen,
More informationHormonal Regulations Of Glucose Metabolism & DM
Hormonal Regulations Of Glucose Metabolism & DM What Hormones Regulate Metabolism? What Hormones Regulate Metabolism? Insulin Glucagon Thyroid hormones Cortisol Epinephrine Most regulation occurs in order
More informationSmoking is Associated with Increased Risk of Osteoporosis in Diabetes Mellitus Patients
Research Article imedpub Journals http://www.imedpub.com DOI: 10.4172/2469-6684.100031 Smoking is Associated with Increased Risk of Osteoporosis in Diabetes Mellitus Patients Tahir Alsaadawi Hilla Teaching
More informationObesity, Insulin Resistance, Metabolic Syndrome, and the Natural History of Type 2 Diabetes
Obesity, Insulin Resistance, Metabolic Syndrome, and the Natural History of Type 2 Diabetes Genetics, environment, and lifestyle (obesity, inactivity, poor diet) Impaired fasting glucose Decreased β-cell
More informationDEXA SCAN POLICY CRITERIA BASED ACCESS
DEXA SCAN POLICY Version: 1718.v2 Recommendation by: Somerset CCG Clinical Commissioning Policy Forum (CCPF) Date Ratified: 01 November 2017 Name of Originator/Author: Approved by Responsible Committee/Individual:
More information